 |
|
|
| | | | | | Dear all,
| | | | | | | | The abstract submission for ISHL12 was closed recently and review of the more than 100 abstracts submitted is currently ongoing!
| | | | | | | | The abstracts contain exciting new data regarding preclinical and translational research, novel therapeutic approaches and improvement of care for dedicated subgroups as well as people living beyond lymphoma.
| | | | | | | | All authors who submitted an abstract will be informed about the outcome of the review by early August, 2022.
| | | | | | | | Accepted abstracts will be published in “HemaSphere”, the official journal of the European Hematology Association (EHA).
| | | | | | | | Additionally, prizes for the best abstracts will be awarded during the ISHL12 opening ceremony.
| | | | | |
|
| | | | | | REGISTRATION IS OPEN | | | | | | | | ISHL12 will be a held as a hybrid meeting from October 22 to 24, 2022.
| | | | | | | | You are eager to participate, to network with colleagues, discuss the latest scientific advances and groundbreaking research presentations and experience the symposia, exhibit and posters?
| | | | | | | | Do not hesitate to register for ISHL12. Please use the online registration.
| | | | | | | | Alternatively, you can contact our organizational team at info@hodgkinsymposium.org.
| | | | | |
|
|
| | | | | | All the best and kind regards!
| | | | | | | | | | | | |
|
|
|
